These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 24156898)

  • 1. HIV-associated neurocognitive disorder.
    Clifford DB; Ances BM
    Lancet Infect Dis; 2013 Nov; 13(11):976-86. PubMed ID: 24156898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dementia and neurocognitive disorders due to HIV-1 infection.
    Ances BM; Ellis RJ
    Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive disorders seen in HIV disease.
    Ungvarski PJ; Trzcianowska H
    Issues Ment Health Nurs; 2000; 21(1):51-70. PubMed ID: 10839052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving clinical phenotypes in HIV-associated neurocognitive disorders.
    Sacktor N; Robertson K
    Curr Opin HIV AIDS; 2014 Nov; 9(6):517-20. PubMed ID: 25203640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are MMSE and HDS-R neuropsychological tests adequate for screening HIV-associated neurocognitive disorders?
    Nakazato A; Tominaga D; Tasato D; Miyagi K; Nakamura H; Haranaga S; Higa F; Tateyama M; Fujita J
    J Infect Chemother; 2014 Mar; 20(3):217-9. PubMed ID: 24462448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection. Neuroradiological, neurophysiological, neuroimmunological, and virological correlates.
    Goodkin K; Wilkie FL; Concha M; Asthana D; Shapshak P; Douyon R; Fujimura RK; LoPiccolo C
    Neuroimaging Clin N Am; 1997 Aug; 7(3):561-79. PubMed ID: 9376968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated research nosology for HIV-associated neurocognitive disorders.
    Antinori A; Arendt G; Becker JT; Brew BJ; Byrd DA; Cherner M; Clifford DB; Cinque P; Epstein LG; Goodkin K; Gisslen M; Grant I; Heaton RK; Joseph J; Marder K; Marra CM; McArthur JC; Nunn M; Price RW; Pulliam L; Robertson KR; Sacktor N; Valcour V; Wojna VE
    Neurology; 2007 Oct; 69(18):1789-99. PubMed ID: 17914061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.
    Kamat A; Lyons JL; Misra V; Uno H; Morgello S; Singer EJ; Gabuzda D
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):234-43. PubMed ID: 22569268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders?
    Zaegel-Faucher O; Laroche H; Tixier M; Morisseau V; Obry-Roguet V; Poizot-Martin I
    AIDS Care; 2021 Mar; 33(3):389-397. PubMed ID: 32279542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy.
    Ellis RJ; Badiee J; Vaida F; Letendre S; Heaton RK; Clifford D; Collier AC; Gelman B; McArthur J; Morgello S; McCutchan JA; Grant I;
    AIDS; 2011 Sep; 25(14):1747-51. PubMed ID: 21750419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cognitive alterations associated with HIV-1 infection and AIDS].
    Christo PP
    Rev Assoc Med Bras (1992); 2010; 56(2):242-7. PubMed ID: 20499003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda.
    Abassi M; Morawski BM; Nakigozi G; Nakasujja N; Kong X; Meya DB; Robertson K; Gray R; Wawer MJ; Sacktor N; Boulware DR
    J Neurovirol; 2017 Jun; 23(3):369-375. PubMed ID: 27995575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurologic complications of HIV infection.
    Spudich SS; Ances BM
    Top Antivir Med; 2012; 20(2):41-7. PubMed ID: 22710906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-associated neurocognitive disorders at Moi teaching and referral hospital, Eldoret, Kenya.
    Mohamed AA; Oduor C; Kinyanjui D
    BMC Neurol; 2020 Jul; 20(1):280. PubMed ID: 32664858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-associated neurocognitive disorders (HAND).
    Elbirt D; Mahlab-Guri K; Bezalel-Rosenberg S; Gill H; Attali M; Asher I
    Isr Med Assoc J; 2015 Jan; 17(1):54-9. PubMed ID: 25739180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on HIV dementia and HIV-associated neurocognitive disorders.
    Brew BJ; Chan P
    Curr Neurol Neurosci Rep; 2014 Aug; 14(8):468. PubMed ID: 24938216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for Evaluation and Management of Cognitive Disorders in HIV-Positive Individuals.
    Underwood J; Winston A
    Curr HIV/AIDS Rep; 2016 Oct; 13(5):235-40. PubMed ID: 27353598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An initial screening for HIV-associated neurocognitive disorders of HIV-1 infected patients in China.
    Zhang Y; Qiao L; Ding W; Wei F; Zhao Q; Wang X; Shi Y; Li N; Smith D; Chen D
    J Neurovirol; 2012 Apr; 18(2):120-6. PubMed ID: 22411002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.